AMA/ASHP Pharmacogenomics Virtual Summit Series: Summit #6: Future state and driving adoption
Please note: This activity was given as a live webinar on March, 2021. If you claimed credit for that activity, you should not claim credit for this activity.
ACPE Activity Number: 0204-9999-21-009-H04-P
Release Date: 03/22/2021
Expiration Date: 03/18/2024
Activity Date: March 18, 2021
Activity Type: Knowledge-based
CE Credits: 2
Activity Fee: Free of charge
Activity Overview
Learn why pharmacogenomics is worthy of institutional investment and how research, education, and direct-to-consumer testing will impact the future of pharmacogenomics.
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Society of Health-System Pharmacists designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
This activity was planned in cooperation with the American Medical Association.This continuing pharmacy and medical education activity is designed for healthcare professionals interested in pharmacogenomics. The activity is meant for audiences with all knowledge levels.
Learning Objectives
After participating in this activity, participants should be able to:
- Recognize the value of pharmacogenomics for your institution
- Identify the current and future state of pharmacogenomics research
- Describe the impact of consumer pharmacogenomic testing
- Give examples of best practices for pharmacogenomics education
Schedule of Activities
- Introduction & series highlights
- Making the case for institutional investment
- Research: Current state & future directions
- Consumer pharmacogenomic testing
- Education: Current state & future directions
- Q&A
- Reactor panel
- Patient
- Payer
- CEO
- Future directions & wrap-up
Faculty
- Moderator:
- Dan M. Roden, MD., professor of medicine, pharmacology, and biomedical informatics and senior vice president for personalized medicine at Vanderbilt University Medical
- Speakers:
- Alicia Zhou, Ph.D., Chief Science Officer, Color Genomics
- George E. MacKinnon III, Ph.D., M.S., R.Ph., FASHP, FNAP, Founding Dean School of Pharmacy, Professor Pharmacy, Family Medicine, and Institute for Health and Equity, Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin
- Peter J. Hulick, M.D., MMSc, FACMG, Medical Director of the Mark R. Neaman Center for Personalized Medicine, Division Head, Center for Medical Genetics, NorthShore University HealthSystem
- Trish Brown, M.S., CGC, Director, AMR Payer Partner and Field Market Access Lead, Illumina
- Jill Hagenkord, M.D., FCAP, Chief Medical Officer, Optum Genomics
- Josh F. Peterson, M.D., M.P.H., FACMI, Professor of Biomedical Informatics and Medicine, Vanderbilt University Medical Center
- William E. Evans, Pharm.D. Emeritus Faculty Member Past-President and CEO St. Jude Children’s Research Hospital
Disclosures
All planners, program chairs, presenters, reviewers and ASHP staff report no financial relationships relevant to this activity.
Methods and CE Requirements
This activity consists of one recorded webinar presentation. This is a 6 part series.
Important Note – ACPE 60 Day Deadline:
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activity.